Run by husband-and-wife team Ugur Sahin and his wife Ozlem Tureci, BioNTech wanted to use the technology to create individualised cancer therapies. Matthias Kromayer, a general partner at the ...

“We see a significant opportunity at the intersection of AI and immunology by computational design of new precision immunotherapies,” said BioNTech chief executive Ugur Sahin. “This ...

EU residents will have access to Omicron-adapted vaccines before the start of the winter season," said Prof Ugur Sahin, BioNTech's chief executive. The companies said they are also planning to ...

BioNTech co-founder Ugur Sahin said the company believes the active ingredient has the potential to set a new standard of treatment in certain cancers. Several studies with the active ingredient ...

With our capabilities, we believe BioNTech is uniquely positioned to develop personalized, yet scalable cancer treatments based on mRNA,” said Prof. Ugur Sahin, M.D., Co-Founder and Chief ...

"Adults aged 50 years and older as well as vulnerable populations like cancer patients are at an increased risk of shingles," said BioNTech's chief executive Ugur Sahin, who was raised and ...

With our capabilities, we believe BioNTech is uniquely positioned to develop personalized, yet scalable cancer treatments based on mRNA,” said Prof. Ugur Sahin, M.D., Co-Founder and Chief Execut ...

BioNTech SE operates as immunotherapy company ... The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

With our capabilities, we believe BioNTech is uniquely positioned to develop personalized, yet scalable cancer treatments based on mRNA,” said Prof. Ugur Sahin, M.D., Co-Founder and Chief Executive ...